Clinical Trial Detail

NCT ID NCT03747419
Title Avelumab and Radiation in Muscle-Invasive Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

invasive bladder transitional cell carcinoma

Therapies

Avelumab

Age Groups: senior adult

No variant requirements are available.